SHINGRIX vaccine 0.5 ML Prefilled Syringe

RxCUI
2719778
RxNorm name
SHINGRIX vaccine 0.5 ML Prefilled Syringe
Display name
SHINGRIX vaccine 0.5 ML Prefilled Syringe
Full name
SHINGRIX vaccine 0.5 ML Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125614ShingrixZoster Vaccine Recombinant, Adjuvanted351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0280849d-5c78-4a9d-8941-4eab429f6bd8SHINGRIX vaccine 0.5 ML Prefilled Syringe [PSN] · 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Prefilled Syringe [Shingrix] [SBD] · 0.5 ML Shingrix 0.1 MG/ML Prefilled Syringe [SY] · Shingrix vaccine 0.5 ML Prefilled Syringe [SY]423These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260213
c46e8702-5680-462b-a093-0c7720f77020SHINGRIX vaccine 0.5 ML Prefilled Syringe [PSN] · 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Prefilled Syringe [Shingrix] [SBD] · 0.5 ML Shingrix 0.1 MG/ML Prefilled Syringe [SY] · Shingrix vaccine 0.5 ML Prefilled Syringe [SY]41These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260306